FindTrial
Sign In

The impact of metagenomic next-generation sequencing on clinical decision-making in neonatal wards: a historical controlled study

The impact of metagenomic next-generation sequencing on clinical decision-making in neonatal wards: a historical controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085787
Enrollment
Unknown
Registered
2024-06-18
Start date
2024-06-30
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal infectious diseases

Interventions

sent for mNGS group:None
not sent for mNGS group:None

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 0.1 Years

Inclusion criteria

Inclusion criteria: Meet the standard of macrogene next generation sequencing

Exclusion criteria

Exclusion criteria: Incomplete clinic data

Design outcomes

Primary

MeasureTime frame
Clinical decision;—

Secondary

MeasureTime frame
MNGS report issuing time;Consistency with the culture results;Positive rate;Hospitalization days;Proportion of ultra-broad-spectrum antibiotics used;Duration of antibiotic use;Incidence of nosocomial infection;Mortality;—

Countries

China

Contacts

Public ContactWang Jianhui

Children's Hospital of Chongqing Medical University

wangjh805@126.com+86 136 7842 8167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026